E. Sarac et al., RESPONSE TO HIGH-DOSE INTERFERON-ALPHA AFTER FAILURE OF STANDARD THERAPY IN MPGN ASSOCIATED WITH HEPATITIS-C VIRUS-INFECTION, American journal of kidney diseases, 30(1), 1997, pp. 113-115
A 42-year-old man developed mixed cryoglobulinemia secondary to hepati
tis C virus (HCV) infection with hypocomplementemia and nephrotic synd
rome. His renal biopsy showed membranoproliferative glomerulonephritis
type I (MPGN). Despite treatment with interferon-alpha, three million
units three times a week for a total of 6 months, the patient continu
ed to have hypocomplementemia, cryoglobulinemia, and nephrosis. After
a course of high-dose interferon-alpha treatment consisting of ten mil
lion units daily for 2 weeks followed by 10 million units three times
per week for an additional 6 weeks, HCV RNA and cryoglobulin testing b
ecame negative, complement levels increased to normal levels, and neph
rotic syndrome remitted. This case confirms an association between HCV
infection and MPGN and suggests a role for high-dose interferon-alpha
treatment when conventional interferon therapy fails. (C) 1997 by the
National Kidney Foundation, Inc.